Xigen SA

1 in Phase 3

Quick facts

Phase 3 pipeline

XG-102
XG-102 is a small molecule that targets the [insert target here, if known].

Phase 2 pipeline

XG-104

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: